Hendra - The virus, the vaccine, the discussion.

  • Home
  • Hendra - The virus, the vaccine, the discussion.

Hendra - The virus, the vaccine, the discussion. Discussing Hendra virus, Hendra virus vaccine, Hendra virus reactions and other related information - without defamation.

Positive outcome for Hendra antibody trial4 February 2020A process developed by University of Queensland researchers to ...
25/03/2020

Positive outcome for Hendra antibody trial

4 February 2020
A process developed by University of Queensland researchers to produce larger quantities of the Hendra virus therapeutic antibody could be expanded to manufacture treatments for other potentially deadly viruses around the world.

Researchers at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) used this process to produce material for Queensland Health’s world-first human Hendra virus clinical trial.

Professor Trent Munro, Director of the National Biologics Facility (NBF) based at AIBN, said the ability to produce anti-bodies at larger scales, coupled with formal regulatory approval via clinical trials, will play an important role in mitigating the impact and spread of these diseases.

“Working with Queensland Health, Uniformed Services University of the Health Sciences (USU) and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), we obtained an antibody-producing cell line and then developed an optimised process to produce the larger amounts required for human clinical use,” Professor Munro said.

“We’re very fortunate to have a facility such as UQ’s NBF as it offers a unique capability to manufacture these novel products – normally this would only be possible at great expense and long timelines within a commercial facility.”

Hendra is a rare but deadly henipavirus that infects fruit bats, however it can be transmitted to horses, and then passed on to humans who have had close contact with an infected horse.

The therapeutic antibody, m102.4, developed by Professor Chris Broder and his team at the USU and the National Institutes of Health in the US, blocks the virus’ entry to healthy human cells enabling the immune system to fight it off.

It was originally used on compassionate grounds, in a small number of people who had experienced a high risk exposure to the virus, however it was unclear if the use of the monoclonal antibody influenced the outcome.

Professor Munro said that there was potential to use the antibody against another henipavirus such as the lethal Nipah virus – listed by the World Health Organisation as a priority pathogen with epidemic potential.

“There are regular outbreaks of Nipah in Asia, so having a treatment option in these countries will be critical,” he said.

“The ability to produce the m102.4 antibody at increasingly larger scales coupled with formal regulatory approval via clinical trials will play an important role in mitigating the impact and spread of these diseases.

“Enabling quick, technology-driven solutions to very serious disease outbreaks is an area where we need continued investment, or we risk not being able to respond appropriately in the future.”

The results of the trial, which was funded by Queensland Health, the National Health and Medical Research Council and the National Hendra Virus Research Program, have been published in The Lancet Infectious Diseases journal.

Media: Professor Trent Munro, [email protected], +61 7 3346 4100; AIBN Communications, [email protected].

Source: https://www.uq.edu.au/news/article/2019/12/positive-outcome-hendra-antibody-trial

12/03/2020

As per the RAS Hendra Policy and Endemic Postcode list (see below), horse exhibits stabled in endemic Hendra Virus postcodes MUST be vaccinated and a CURRENT vaccination certificate supplied to the Horse Section Office prior to arriving on the showground.

If you have not already sent it - Could you please send a copy of your current vaccination certificate to [email protected]

Unless there is adequate evidence of current Hendra Virus vaccination prior to your arrival, your exhibit will not be eligible to compete in 2020 Sydney Royal Horse Competitions.

However, for those exhibits in endemic Hendra virus postcodes who do not have current vaccination, we now provide another option of a veterinary administration of the Titer test within 14 days of the exhibit's arrival at the Show.

If the test is carried out by your veterinarian, you must provide a veterinary certificate that the test was successfully carried out, along with results, to the RAS before arrival on the showground. This certification is to be emailed to [email protected] prior to your arrival.

The Vet has confirmed that you do not have to vaccinate for Hendra Virus as long as the test proves a minimum level of antibodies that shows the horse has immunity to the virus from previous vaccinations. (to be conducted within 14 days of the exhibit's arrival at the Show).
You will need to consult with your local veterinarian to do this.

The exhibitor must provide a veterinary certificate that the test was successfully carried out, along with results, to the RAS before arrival on the showground. The Titre Test certification must be emailed to [email protected] prior to the exhibits arrival.

Source:. https://www.theland.com.au/story/6355621/hendra-vaccine-under-microscope-in-court-class-action/Case claims vacc...
25/12/2019

Source:. https://www.theland.com.au/story/6355621/hendra-vaccine-under-microscope-in-court-class-action/

Case claims vaccine maker overstated Hendra virus

John Ellicott
30 Aug 2019, 11:30 a.m.

Vets attend to a possible case of Hendra on a Mid-North Coast property. Vets have been the victims of most Hendra cases in humans reported since 1994 (about 7).

The Thoroughbred industry is increasing its vaccination of horses against the bat-carrying Hendra virus as a class action is underway challenging the vaccine manufacturer over its statements about the threat of the virus.

The class action listed for hearing shortly in the Federal Court alleges Zoetis Australia overstated the risks of Hendra virus to the horse community.

Zoetis Australia denies the claim and in a statement provided for The Land said:

"The vaccine is safe, effective and fully approved by Australia's highly regarded regulator. Since 2012, Australian veterinarians have administered hundreds of thousands of vaccinations, including to some of the most expensive racehorses in the world. Vaccination protects horses and everyone who comes into contact with them. The action has no merit."

The class action, that has 130 people or more joined to it, conducted by LHD lawyers, also alleges a number of severe reactions to the vaccine have occurred in horses.

The vaccine sold as Equivac HeV was developed by the CSIRO and has full approval from the APVMA. The vaccine must be administered by a veterinarian. It follows a pattern of an initial vaccination, followed a few weeks later by a second vaccination, another one six months later and then a booster every year. The cost for each vial of vaccine is about $50, plus vet costs, which could be as high as $200 per vaccination.

The vaccine was created after the first fatal case of Hendra passing from a horse to human in 1994, the death of Vo Rogue's trainer Vic Rail after contracting the disease in his Hendra stables in Brisbane, that also killed 20 horses. The event sent shockwaves through the public that a virus, virulent but not as contagious as Ebola virus, could be so deadly. It is passed on to horses from bats, specifically four species of flying foxes, with horses eating feed contaminated by bat urine, saliva or birth products.

A Queensland parliamentary committee in 2016 declared that Hendra virus (HeV) was "relatively rare and difficult to catch. However, if a horse or human does contract the virus, there is no cure and they will most likely die."

All confirmed human cases so far to date have been where people have had high exposure to a horse's body fluids, such as doing autopsies on horses. The virus can incubate for up to 21 days in a human, has devastating effects of the body, attacking the nervous system with possible meningitis or encephalitis (inflammation of the brain), headaches, high fever, and sometimes convulsions and coma.

Four of the seven people in Australia infected during the period 1994 to 2012 died. Five of the seven were either veterinarians or were assisting vets.

From 1994 to 2016 inclusive, there have been more than 70 sporadic confirmed cases of Hendra virus infection in horses. (There are 900,000 domesticated horses in Australia).

A statement of claim for the case says "between 1994 and 2011, there were: (a) 23 incidents of Hendra in horses in Queensland affecting a total of 55 horses; (b) 9 incidents of Hendra in horses in NSW affecting a total of 11 horses; and (c) no other incidents of Hendra in horses in other parts of Australia."

The first test of the vaccine started in 2012 before its public release, and world-leading animal vaccine manufacturer Zoetis (formerly Pfizer) obtained the rights to manufacture it. The vaccine research by the CSIRO won an international award. It was a world-first commercial vaccine for a bio-safety level-4 disease agent and the CSIRO said it was "vigorously tested". The CSIRO says the vaccine "enhances security for the Australian horse industry and reduces time spent in quarantine" and minimised the chance of Hendra virus mutating.

The Australian Veterinary Association recommends that all horses in Australia are vaccinated against the Hendra virus, but there is no legislated vaccination.

Zoetis says there has has been infinitesimal reactions in horses from receiving the HeV vaccination.

In the applicant's statement of claim it says: "From on or about August 2012, Zoetis presented to each registered veterinary surgeons who undertook the registration module materials , in which Zoetis stated: 'Vaccine Safety Update: analysis of the first 25,500 doses administered to horses have shown a low adverse reaction rate, with no serious or life threatening reactions involved. 0.22 per cent adverse reaction rate to date'"

The claimant says at "the risk of a horse becoming infected with Hendra in those parts of Queensland and NSW in the vicinity of the incidents identified" in its claim "was and is low", and also that in those parts of Australia where fruit bats are present outside the vicinity of the areas identified "was and is extremely low".

The claimant alleges that Zoetis From 2 March 2013 and throughout the relevant period of the claim, Zoetis represented that there was a serious risk of horses contracting Hendra in all areas of Australia in which flying foxes were present. "By making the Geographic Spread Representation, Zoetis engaged in conduct in trade or commerce within the meaning of s 18 of the Australian Competition Law (ACL). The Geographic Spread Representation was misleading or deceptive, or likely to mislead or deceive within the meaning of s 18 of the ACL."

The case is soon to head to court after interlocutory hearings over costs.

CASE STUDY

Each afternoon, Sharon watches her daughter Mia, 9, come home from school and walk out to the stable to sit quietly by her Welsh pony Angel.

She waits and waits, waiting for the time she can ride Angel again - but it may be a fruitless wait.

Angel suffered from severe laminitis shortly after she received the Hendra vaccine back in May at a Gold Coast property. The laminitis unusually was in all four of Angel's feet, making her having to have special shoes to ease the pain in the laminae soft tissue. A first vet did not give any basis for the laminitis, while a second vet who inspected the horse said he believed it was a reaction to the virus. Blood tests taken for Ross River fever and other possible sources, paid for by the manufacturer of the vaccine, Zoetis, proved inconclusive. Zoetis also wanted Angel tested at a facility at Gympie, but she was too sick to move.

Zoetis had paid for all the subsequent vet bills - amounting to about $3500, but have not admitted to liability to do with the vaccination. Sharon has been in phone conversation with a Zoetis Australia executive but has received nothing in writing.

For Sharon, a former NSW resident who now lives on the Gold Coast, it has been heartbreaking watching her daughter wait by Angel's side. They've bought a new pony for her (Charlie) - and the family has vowed not to get the new horse vaccinated for fear the same thing could happen again.

"At one stage after the vaccination Mia was competing on Angel and I said to myself 'oh my god, Angel has stopped still, I've got to get Mia off, she's going to roll'. We got Angel back home. She was up the top of the paddock and wouldn't walk. A vet came on the Monday and said he wasn't sure what Angel had, he had the Hendra gear on. I got a second vet's opinion and he said straight off the bat "she's had a Hendra (vaccine) reaction'. I didn't even know you could get a reaction."

Zoetis paid for multiple tests, including for Ross River fever but nothing was discovered. "Every test came back negative," Sharon says.

Angel is slowly recovering and is about 40 per cent back to her original health. But she is likely to stay stabled for another six months.

"The hardest part for me is seeing my daughter, she is so upset at what's happened, she's changed," Sharon said.

Sharon says she has now paid over $10,000 for horses and faces a bill of about $200 a week for hay for the two horses. They would never sell Angel or have her euthanased, as she was part of the family.

COURT CLAIMS

The class action claims that Zoetis over-stated the risks of horses contracting the Hendra virus in a number of pamphlets. About 130 people at his stage have joined the class action. When the case proceeds, applicants will have to opt in or opt out - meaning if the court finds against Zoetis, only those involved in the action would benefit from any possible damages decision. A damages decision could be global, or made on a case by case basis.

The lead applicant is Rachael Abbott, who allegedly lost her job after she refused to get her horse vaccinated for a second time while she was working at a Central West NSW feedlot. Ms Abbott started work as a stockperson with JBS Caroona Feed Lot (JBS) in June 2014, and owned a stockhorse Primetime, an 11-year-old mare, and had an interest in another horse Ervines Jive, a five-year-old mare.

She claims that JBS told her the horse need to be vaccinated for Hendra virus. The claim alleges after the first vaccination "Primetime had suffered an injection site reaction, oedema, pain and Pyrex/a and became depressed and touch sensitive after the administration of the HeV injection. She experienced swelling in her joints and over kidneys, pale or white gums, rapid breathing, weight loss, disorientation and was stiff in her movements. As a result of this, Primetime required four months of veterinary care." She said her $30,000 horse could not be sold.

"The Applicant was directed to allow but refused to have any further injections administered to her horses and as a result her employment was terminated on 20 March 2015."

THOROUGHBRED INDUSTRY

The thoroughbred industry is vaccinating most of its horses, especially following the scare from a case of Hendra at a property outside of Scone. The case sent shockwaves through the Hunter breeding industry, one of the most important thoroughbred centres in the world, and it is now a requirement that any mare presented to a Hunter stud must be vaccinated.

Leading Australian horse trainer Chris Waller has directed all his horses be vaccinated. Waller's pre-trainer Ollie Koolman, who looked after star mare Winx, said it was proper practice to get a horse vaccinated because of the threat to humans.

"Chris Waller racing has directed all its horses be vaccinated," Koolman said. "We've embraced the vaccination concept. We've done a number of them already, a few have had a temperature, but that is about it. You have to remember we are protecting humans as well as horses. We've never done it before, but now we are taking a blanket approach. The vet administers and it's well regulated. it's just part of our vaccination program that includes protecting against strangles and tetanus."

Scone trainer Rod Northam has had 40-50 of his horses vaccinated. "As soon as we heard of the Scone case we got our horses vaccinated. I employ staff so if any of my staff or myself got the virus that would be terrible as it is preventable.I believe most of the stud farms are doing it now. We've done 40 to 50 horses and just one was a bit swollen in the injection area for three to four days. Some have been a little flat after the second shot. The vets say that from 24-48 hours the horses can be a little low. As far as their racing I have seen no effects at all. It is expensive, but what is the cost of a human life? It is a no-brainer to get them vaccinated."

He said he didn't believe bats were frequently at the Scone property where the infection occurred but they might have been feeding on the gum trees. He said horse owners should be aware of that when paddocking animals.

THE CASE AT SCONE

A case of Hendra was discovered for the first time in the Hunter at Scone in early June. The last Hendra case in NSW was an unvaccinated horse on a property near Tweed Heads in September 2018. The most southern case reported previously was at Kempsey in 2013.

Three tests confirmed Hendra in the Scone horse, from a property that was well away from the major breeding studs.

The case was highly unusual in terms of what actually happened on the ground and for it being way out pf the normal zone for Hendra.

In its summation of the case supplied to The Land. The DPI said: "Samples from the horse infected with Hendra at Scone in early June were taken by the District Veterinarian.

"The horse was found to be positive on PCR (DNA detection of the virus) on separate swabs (re**al, nasal and oral) as well as on blood (clotted and EDTA) by the State Veterinary Laboratory. The positive results were also confirmed at the Australian Animal Health Laboratory.

"Flying foxes including black headed flying foxes were detected in the area within flying distance of the property.

"The property was under restriction for 21 days and animals thought to have been exposed to the positive horse or its discharges were segregated and their health status monitored. All remained healthy during the 21 days. All restrictions on the property under the NSW Biosecurity Act have been removed.

"NSW Health identified 10 people with varying levels of exposure to the positive horse and they were all assessed. All remained healthy during the 21 days.

"Tracing of horses who had moved off the property during the risk period determined that all were low risk and no action required.

"Meetings have been held with veterinarians around Scone to update them on the case and provide information and resources."

QUEENSLAND INQUIRY

On 25 February 2016 the Queensland Legislative Assembly agreed to a motion that the "Agriculture and Environment Committee inquire into and report on the Hendra virus (HeV) EquiVacc® vaccine and its use by veterinary surgeons in Queensland".

The parliamentary committee concluded that that "Hendra virus vaccination not be made mandatory but left to the discretion of equestrian event organisers to require as a condition of entry and for horse owners to decide based on risk".

"The APVMA, Zoetis and the AVA have argued that the levels of adverse reactions to the HeV vaccine are low and well within the normal acceptable range. The APVMA has reported only seven deaths of horses 'possibly' linked and no deaths 'probably' linked to vaccinations to date," the report tabled in parliament said.

"Despite these statistics, many horse owners are adamant that adverse reactions to the vaccine are more prevalent and under-reported (by vets to Zoetis to APVMA, and then reported by APVMA), and that vets and Zoetis have clear vested interests in not reporting adverse reactions."

The committee's own survey of horse deaths highlighted challenges with adverse event reporting. They decided not to recommend legislation to make the Hendra virus vaccine mandatory.

Many of these issues will be subject to submissions in the court case. The lawyers representing the class action are filing an FOI application to learn more about the Scone Hendra case.

The horse was a 25-year-old ex polo horse and had been there a long time.The legal team is eager to know if any equipment was brought onto the property in horse floats.

There is a directions hearing set down for September 13 before Justice Michael Lee in the Federal Court in Sydney. The court has allowed an amended statement of claim.

Whether you're for or against the vaccine, the potential for a stall side test to be fully developed and made available ...
17/12/2019

Whether you're for or against the vaccine, the potential for a stall side test to be fully developed and made available to vets and the public in the near future, is a positive.

Fantastic result!
We have now raised over $9,000 towards Professor Macdonald's rapid test for hendra and have enabled Professor Macdonald to re-start work on the hendra test.
The other news is that the GoFundMe in Rambler's honor has raised lots of interest from industry groups, particularly in QLD, and we are looking forward to their donations. There is also a few grants that are looking promising.
Thank you again to everyone who have donated and supported this test.

https://www.gofundme.com/f/rambler039s-legacy?utm_source=facebook&utm_medium=social&utm_campaign=p_cp+share-sheet

Q1.  If titer testing was affordable and an acceptable way of determining when booster vaccinations were necessary there...
26/11/2019

Q1. If titer testing was affordable and an acceptable way of determining when booster vaccinations were necessary thereby reducing the risk of over vaccination, would you feel safer vaccinating for Hendra?

The question is asked in relation to this vet's stance (see attachment) on titer testing prior to 'booster' vaccinating.

Q2. Do you agree with him? Please share the reason for your answer.

https://m.facebook.com/story.php?story_fbid=2965496310146113&id=1690995850929505

Every time a pet is given a booster vaccine, without first checking the immunity status of that pet, malpractice has occurred.

If a pet has immunity, easily proven by a simple affordable blood test, there is no medical benefit to a booster vaccine. However that vaccine can sicken the pet, or worse kill it.

Order an affordable titer today and Protect The Pets!

http://www.protectthepets.com/order-a-titer.html

Doc

𝐃𝐈𝐒𝐂𝐔𝐒𝐒𝐈𝐎𝐍 - 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓 𝐎𝐅 𝐇𝐄𝐍𝐃𝐑𝐀 𝐑𝐀𝐏𝐈𝐃 𝐒𝐓𝐀𝐋𝐋 𝐒𝐈𝐃𝐄 (𝐑𝐒𝐒) 𝐓𝐄𝐒𝐓.The Government and many service providers continue to str...
23/09/2019

𝐃𝐈𝐒𝐂𝐔𝐒𝐒𝐈𝐎𝐍 - 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓 𝐎𝐅 𝐇𝐄𝐍𝐃𝐑𝐀 𝐑𝐀𝐏𝐈𝐃 𝐒𝐓𝐀𝐋𝐋 𝐒𝐈𝐃𝐄 (𝐑𝐒𝐒) 𝐓𝐄𝐒𝐓.

The Government and many service providers continue to strongly recommend and promote the use of the Hendra vaccine as the single most effective way of reducing the risk of Hendra virus infection in horses. However, the vaccine is expensive, with the vaccination schedule being two doses 2-3 weeks apart, with an initial 6-month booster, followed by annual boosters thereafter and this can make the cost of maintaining a ‘protected’ vaccination status difficult for horse owners. Aside from the cost, we must also acknowledge the huge controversy regarding potential side-effects of the vaccine.

According to the Australian Pesticides and Veterinary Medicines Authority the “probable” side-effects being presented after the primary vaccination course include but are not limited to: injection site reaction, oedema, lethargy, pain, anorexia, stiffness, colic and lameness. That information, in combination with Recommendation 4 of the Agriculture and Environment committee’s tabled report No. 24, gives horse owners reason to question the efficacy of the vaccine, and potential for adverse reactions in their horses:

𝐑𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐚𝐭𝐢𝐨𝐧 𝟒
“Advising owners of vaccine information and ‘off label’ risks
That the Department of Agriculture and Fisheries, in conjunction with the Australian Veterinary Association, remind veterinarians of their obligations to provide Hendra vaccine
information to horse owners and to advise owners of the risks to horses before administering the vaccine ‘off label’. This includes administering the vaccine with other medicines.”

𝐐𝐮𝐞𝐞𝐧𝐬𝐥𝐚𝐧𝐝 𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞
𝐄𝐱𝐜𝐞𝐫𝐩𝐭:
“The Queensland Government supports the recommendation.
The Department of Agriculture and Fisheries will continue to provide advice consistent with the use of the vaccine as approved by the Australian Pesticides and Veterinary Medicine Authority (APVMA) and work with the Australian Veterinary Association and Queensland Veterinary Surgeons Board to remind veterinarians about their obligation to provide horse owners with advice about any risks associated with off label use of the vaccine.
To enable more detailed information to be provided to veterinarians about the risks associated with off label use, the department has written to the APVMA and sought advice on “off label” use of the vaccine (i.e. any use of the vaccine not in accordance with the labelled instructions).
The APVMA advised that in the case of the Hendra virus vaccine, the applicant did not provide any data that examined the efficacy and/or safety of the vaccine when used with other vaccines or chemical products, for use in sick or immunocompromised animals or for use in pregnant mares during critical stages of pregnancy.
In the absence of such data, the APVMA has indicated that they require product labels to include a precautionary statement that the efficacy and safety of the vaccine when used in these scenarios has not been studied and is not known.”

Given the above, it’s not unreasonable for some horse owners to hesitate to vaccinate their horses, and many of those that choose not to vaccinate, are having to wait for an exclusion test to be performed and a result received, prior to a vet treating their horse as necessary. This brings us to discuss how the development of a rapid stall side test might reduce the exclusion testing process time, and in urgent cases, potentially save a non-infected horse by enabling life-saving treatment on a faster timeline.

In the aforementioned report (No. 24), Hendra virus EquiVac® vaccine and its use by veterinary surgeons in Queensland, tabled on 21 October 2016 in the Legislative Assembly, 𝗼𝗳 𝗽𝗮𝗿𝘁𝗶𝗰𝘂𝗹𝗮𝗿 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁 𝘁𝗼 𝘁𝗵𝗲 𝘁𝗼𝗽𝗶𝗰 𝗼𝗳 𝗿𝗮𝗽𝗶𝗱 𝘀𝘁𝗮𝗹𝗹-𝘀𝗶𝗱𝗲 𝘁𝗲𝘀𝘁𝗶𝗻𝗴, 𝘄𝗮𝘀 𝘁𝗵𝗲 𝗳𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴 𝗿𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗮𝘁𝗶𝗼𝗻:

𝐑𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐚𝐭𝐢𝐨𝐧 𝟐
"Development and evaluation of a stall side test
That the Department of Agriculture and Fisheries support the development of a rapid stall-side test for Hendra virus as a further aid to check the Hendra virus status of horses in the field, and determine whether a rapid stall side test could negate the need for HeV exclusion testing."

𝐓𝐡𝐞 𝐐𝐮𝐞𝐞𝐧𝐬𝐥𝐚𝐧𝐝 𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞 did not support the recommendation in full, stating that they supported technological advances in the testing for and diagnosis of Hendra virus, including the development of point of care testing, but that they anticipated it would take a number of years for suitable alternative testing methods to be developed that provided assurance and appropriate safety, sensitivity and specificity (i.e. accuracy).

Despite the Dept of Agriculture and Fisheries recommendation in 2016, a rapid stall side test is yet to come to fruition. Hence, seven years after the EquiVac HeV vaccine was developed, the topic of Hendra, the virus and the vaccine, remains as controversial as it ever was.

𝐓𝐰𝐨 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐫𝐢𝐦𝐚𝐫𝐲 𝐢𝐬𝐬𝐮𝐞𝐬 𝐛𝐞𝐢𝐧𝐠:
• the incidence and impact of adverse reactions by horses following vaccination; and

• sick horses not receiving timely treatment until the results of a Hendra virus exclusion test is returned, most commonly due to many equine veterinarians instigating a no vaccination/no treatment policy.

With regards to the current exclusion test available, information suggests that the process of HeV testing for diagnosis/exclusion from 'blood tests to result being received', can take (on average) anywhere between 1 – 5 days, therefore it’s not unrealistic to suggest that sick horses have, and will, suffer and (in some cases) die, whilst waiting for the results of a standard Hendra virus exclusion test to clear them for treatment.

The realism of this situation brings home the importance of the rapid stall-side test. The information available on a proposed rapid stall-side test, tells us that if this test were available, rather than wait days to find out if your horse is/or is not Hendra positive, (and can access treatment), you might be expected to wait only 10 – 15 minutes to find this out. If this information is accurate, it means that within half an hour of your vet attending and performing a rapid stall-side test:

• your vet could confidently treat your horse (if the horse returned a negative result) without fear of Hendra infection; or

• if it returned a positive result your vet could euthanise the horse, putting it quickly out of its misery

𝐁𝐮𝐭 𝐦𝐨𝐬𝐭 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭𝐥𝐲, aside from the obvious benefits already mentioned, a rapid stall side test would:

• 𝒆𝒏𝒂𝒃𝒍𝒆 𝒂 𝒎𝒖𝒄𝒉 𝒒𝒖𝒊𝒄𝒌𝒆𝒓 𝒕𝒊𝒎𝒆𝒇𝒓𝒂𝒎𝒆 𝒇𝒐𝒓 𝒕𝒉𝒆 𝒂𝒔𝒔𝒆𝒔𝒔𝒎𝒆𝒏𝒕 𝒂𝒏𝒅 𝒕𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕 𝒐𝒇 𝒉𝒖𝒎𝒂𝒏𝒔/𝒐𝒕𝒉𝒆𝒓 𝒂𝒏𝒊𝒎𝒂𝒍𝒔, 𝒇𝒐𝒍𝒍𝒐𝒘𝒊𝒏𝒈 𝒂 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆 𝒓𝒆𝒔𝒖𝒍𝒕.

With all these supposed benefits, it raises the question “𝑤ℎ𝑦 ℎ𝑎𝑠𝑛’𝑡 𝑎 𝑟𝑎𝑝𝑖𝑑 𝑠𝑡𝑎𝑙𝑙-𝑠𝑖𝑑𝑒 𝑡𝑒𝑠𝑡 𝑏𝑒𝑒𝑛 𝑑𝑒𝑣𝑒𝑙𝑜𝑝𝑒𝑑?”

“𝑰𝒇 𝒗𝒆𝒕𝒆𝒓𝒊𝒏𝒂𝒓𝒊𝒂𝒏𝒔 𝒄𝒐𝒖𝒍𝒅 𝒒𝒖𝒊𝒄𝒌𝒍𝒚 𝒅𝒆𝒕𝒆𝒓𝒎𝒊𝒏𝒆 𝒊𝒇 𝑯𝒆𝒏𝒅𝒓𝒂 𝒗𝒊𝒓𝒖𝒔 𝒊𝒔 𝒑𝒓𝒆𝒔𝒆𝒏𝒕 𝒊𝒏 𝒂 𝒔𝒊𝒄𝒌 𝒉𝒐𝒓𝒔𝒆, 𝒕𝒉𝒆𝒚 𝒄𝒐𝒖𝒍𝒅 𝒎𝒐𝒓𝒆 𝒆𝒂𝒔𝒊𝒍𝒚 𝒎𝒂𝒌𝒆 𝒅𝒆𝒄𝒊𝒔𝒊𝒐𝒏𝒔 𝒐𝒏 𝒕𝒓𝒆𝒂𝒕𝒊𝒏𝒈 𝒉𝒐𝒓𝒔𝒆𝒔. 𝑨 𝒓𝒂𝒑𝒊𝒅 𝒕𝒆𝒔𝒕 𝒕𝒉𝒂𝒕 𝒒𝒖𝒊𝒄𝒌𝒍𝒚 𝒅𝒆𝒕𝒆𝒄𝒕𝒔 𝑯𝒆𝒏𝒅𝒓𝒂 𝒗𝒊𝒓𝒖𝒔 𝒊𝒔 𝒄𝒓𝒊𝒕𝒊𝒄𝒂𝒍 𝒇𝒐𝒓 𝒑𝒓𝒆𝒗𝒆𝒏𝒕𝒊𝒏𝒈 𝒖𝒏𝒅𝒖𝒆 𝒔𝒖𝒇𝒇𝒆𝒓𝒊𝒏𝒈 𝒐𝒇 𝒉𝒐𝒓𝒔𝒆𝒔 𝒂𝒏𝒅 𝒓𝒆𝒅𝒖𝒄𝒊𝒏𝒈 𝒕𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕 𝒅𝒊𝒍𝒆𝒎𝒎𝒂𝒔 𝒇𝒐𝒓 𝒉𝒐𝒓𝒔𝒆 𝒄𝒂𝒓𝒆𝒓𝒔. 𝑯𝒐𝒘𝒆𝒗𝒆𝒓, 𝒕𝒉𝒆 𝒕𝒆𝒔𝒕 𝒘𝒐𝒖𝒍𝒅 𝒏𝒆𝒆𝒅 𝒕𝒐 𝒃𝒆 𝒗𝒆𝒓𝒚 𝒔𝒆𝒏𝒔𝒊𝒕𝒊𝒗𝒆 – 𝒔𝒐 𝒕𝒉𝒂𝒕 𝒍𝒐𝒘𝒆𝒓 𝒍𝒆𝒗𝒆𝒍𝒔 𝒐𝒇 𝒕𝒉𝒆 𝒗𝒊𝒓𝒖𝒔 𝒂𝒓𝒆 𝒏𝒐𝒕 𝒎𝒊𝒔𝒔𝒆𝒅.” - USC Qld.

This is where Joanne MacDonald, Joanna Kristoffersen and the research team from the University of the Sunshine Coast come into the story. Joanna Kristoffersen, who used to work as a field officer for Biosecurity Queensland, has (under the supervision of Associate Professor Joanne MacDonald), developed a rapid diagnostic test for the deadly Hendra virus that she says can deliver results within 10 minutes.

"𝐼 𝑐𝑎𝑛'𝑡 𝑔𝑜 𝑖𝑛𝑡𝑜 ℎ𝑢𝑔𝑒 𝑑𝑒𝑡𝑎𝑖𝑙 𝑎𝑠 𝑡𝑜 ℎ𝑜𝑤 𝑡ℎ𝑒 𝑡𝑒𝑠𝑡 𝑖𝑠 𝑝𝑒𝑟𝑓𝑜𝑟𝑚𝑒𝑑 𝑎𝑠 𝑤𝑒 𝑎𝑟𝑒 𝑎𝑤𝑎𝑖𝑡𝑖𝑛𝑔 𝑝𝑢𝑏𝑙𝑖𝑠ℎ𝑖𝑛𝑔, 𝑏𝑢𝑡 𝐼 𝑐𝑎𝑛 𝑡𝑒𝑙𝑙 𝑦𝑜𝑢 𝑡ℎ𝑎𝑡 𝑡ℎ𝑒 𝑑𝑖𝑎𝑔𝑛𝑜𝑠𝑡𝑖𝑐 𝑖𝑠 𝑟𝑎𝑝𝑖𝑑 𝑎𝑛𝑑 𝑖𝑡 𝑐𝑎𝑛 𝑑𝑒𝑡𝑒𝑐𝑡 𝐻𝑒𝑛𝑑𝑟𝑎 𝑣𝑖𝑟𝑢𝑠 𝑟𝑖𝑏𝑜𝑛𝑢𝑐𝑙𝑒𝑖𝑐 𝑎𝑐𝑖𝑑 (𝑅𝑁𝐴) 𝑖𝑛 𝑢𝑛𝑑𝑒𝑟 10 𝑚𝑖𝑛𝑢𝑡𝑒𝑠," Ms Kristoffersen said.

“𝑇ℎ𝑒 𝑡𝑒𝑠𝑡, 𝑖𝑓 𝑤𝑒 𝑐𝑎𝑛 𝑎𝑐𝑞𝑢𝑖𝑟𝑒 𝑓𝑢𝑟𝑡ℎ𝑒𝑟 𝑓𝑢𝑛𝑑𝑖𝑛𝑔, ℎ𝑎𝑠 𝑡ℎ𝑒 𝑝𝑜𝑡𝑒𝑛𝑡𝑖𝑎𝑙 𝑡𝑜 𝑏𝑒 𝑝𝑒𝑟𝑓𝑜𝑟𝑚𝑒𝑑 𝑜𝑛-𝑠𝑖𝑡𝑒 𝑜𝑛 𝑎 𝑠𝑡𝑟𝑖𝑝-𝑟𝑒𝑎𝑑 𝑓𝑜𝑟𝑚𝑎𝑡 𝑐𝑎𝑙𝑙𝑒𝑑 𝑎 𝑙𝑎𝑡𝑒𝑟𝑎𝑙 𝑓𝑙𝑜𝑤 𝑑𝑒𝑣𝑖𝑐𝑒.
𝑇ℎ𝑖𝑠 𝑡𝑒𝑠𝑡 𝑖𝑠 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐, 𝑖𝑡'𝑠 𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑒 𝑎𝑛𝑑 𝑤𝑒 𝑐𝑎𝑛 𝑑𝑒𝑡𝑒𝑐𝑡 𝑛𝑢𝑐𝑙𝑒𝑖𝑐 𝑎𝑐𝑖𝑑𝑠 𝑟𝑎𝑡ℎ𝑒𝑟 𝑡ℎ𝑎𝑛 𝑜𝑡ℎ𝑒𝑟 𝑠𝑛𝑎𝑝 𝑡𝑒𝑠𝑡𝑠 𝑡ℎ𝑎𝑡 𝑢𝑠𝑒 𝑎𝑛 𝑎𝑛𝑡𝑖𝑏𝑜𝑑𝑦 𝑎𝑛𝑡𝑖𝑔𝑒𝑛 𝑚𝑒𝑐ℎ𝑎𝑛𝑖𝑠𝑚.
𝑊𝑒 𝑎𝑟𝑒 𝑤𝑜𝑟𝑘𝑖𝑛𝑔 𝑜𝑛 𝑐𝑜𝑚𝑚𝑒𝑟𝑐𝑖𝑎𝑙𝑖𝑠𝑖𝑛𝑔 𝑖𝑡, 𝑎𝑛𝑑 ℎ𝑜𝑝𝑒𝑓𝑢𝑙𝑙𝑦 𝑤𝑖𝑡ℎ𝑖𝑛 𝑜𝑛𝑒 𝑡𝑜 𝑡𝑤𝑜 𝑦𝑒𝑎𝑟𝑠 𝑤𝑒 𝑚𝑖𝑔ℎ𝑡 𝑏𝑒 𝑎𝑏𝑙𝑒 𝑡𝑜 𝑔𝑒𝑡 𝑡ℎ𝑖𝑠 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 𝑜𝑢𝑡.
𝐼𝑡 𝑙𝑜𝑜𝑘𝑠 𝑠𝑖𝑚𝑖𝑙𝑎𝑟 𝑡𝑜 𝑎𝑛 𝑎𝑡-ℎ𝑜𝑚𝑒 𝑝𝑟𝑒𝑔𝑛𝑎𝑛𝑐𝑦 𝑡𝑒𝑠𝑡."

𝐓𝐚𝐛𝐥𝐞 𝟏: 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐧𝐞𝐰 𝐑𝐚𝐩𝐢𝐝 𝐇𝐞𝐧𝐝𝐫𝐚 𝐭𝐞𝐬𝐭 𝐜𝐨𝐦𝐩𝐚𝐫𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐥-𝐭𝐢𝐦𝐞 𝐏𝐂𝐑 𝐭𝐞𝐬𝐭𝐬. (see attached)

𝐓𝐚𝐛𝐥𝐞 𝟐: 𝐄𝐱𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐇𝐞𝐧𝐝𝐫𝐚 𝐑𝐚𝐩𝐢𝐝 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐭𝐢𝐦𝐞𝐥𝐢𝐧𝐞𝐬. (see attached)

𝐅𝐨𝐫 𝐟𝐮𝐫𝐭𝐡𝐞𝐫 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧, 𝐩𝐥𝐞𝐚𝐬𝐞 𝐜𝐨𝐧𝐭𝐚𝐜𝐭 𝐭𝐡𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫:
𝐀𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐞 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐨𝐫 𝐉𝐨𝐚𝐧𝐧𝐞 𝐌𝐚𝐜𝐝𝐨𝐧𝐚𝐥𝐝, 𝐣𝐦𝐚𝐜𝐝𝐨𝐧𝟏@𝐮𝐬𝐜.𝐞𝐝𝐮.𝐚𝐮, +𝟔𝟏 𝟕 𝟓𝟒𝟓𝟔 𝟓𝟗𝟒𝟒

One of the most recent cases where it’s believed this rapid stall side test had the potential to save a horse’s life, is the case of ‘Rambler’, a champion competition horse, whom along with two other horses, presented at the Charles Sturt University Large Animal Clinic in Wagga Wagga, with suspected plant poisoning.

Despite Rambler having been vaccinated a total of nine times in five years, at the time of presentation for treatment as CSU, his vaccination status was no longer ‘protected’, and therefore, he was refused treatment until the results of a Hendra exclusion test were received. Regrettably, due to the timeframe in which a negative result was received, Rambler was euthanised on compassionate grounds to relieve his suffering.

From the information available it appears that development of the RSS test has stalled due to lack of funding, however this recent incident has once again sparked an outcry for the development of the rapid stall side test to continue through to its release, enabling faster exclusion and treatment of sick horses. Understandably though, there are several steps required before this research can be readily available to veterinarians to use in the field.

If you advocate for the development and release of a Hendra Rapid Stall side test, there are two ways you can donate funds to contribute towards the continuation of this life-changing research.
You can donate directly to the University of the Sunshine Coast where 100% of your donation will go towards Rapid Hendra virus diagnostic technology research, with any donations over $2 being tax deductible.

To donate, you can either contact Senior Development Manager Kate Evans - [email protected] / +61 7 5456 5136 𝐎𝐑
Donate via USC’s payment gateway:
https://payments.usc.edu.au/OneStopWeb/95Q/tran?UDS_ACTION_DATA=YSsmdzVMKnBOWydwQEJDAlknQnQ8LzcbWjQ3VgBGIEIJNy5Q
and select ‘Hendra’ from the Donation type drop down.

Alternatively, as a legacy to their much loved horse, the owners of Rambler have, through an intermediary, initiated contact with USC researchers and created a GoFundMe account where all proceeds will be donated to the USC Hendra Rapid Stall Side research team to help fund completion of the RSS test.

GoFundMe link for Rapid Stall Side Test:
https://www.gofundme.com/f/rambler039s-legacy?fbclid=IwAR08_fV0_H1-LCwgOwicrq655xa89dLrAiUbPriki1LcQBUCiFg_p5bI0Bo

𝐒𝐨𝐮𝐫𝐜𝐞𝐬:
•https://cabinet.qld.gov.au/documents/2017/Apr/Hendra/Attachments/Response.PDF
https://www.abc.net.au/news/rural/2016-08-01/hendra-test-fast-equine-veterinary-disease/7672780
https://www.usc.edu.au/connect/giving-to-usc/giving-opportunities/hendra-virus-research
http://apvma.gov.au/node/15786

© Hendra - The virus, the vaccine, the discussion. 2019

Address


Website

Alerts

Be the first to know and let us send you an email when Hendra - The virus, the vaccine, the discussion. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Address
  • Alerts
  • Contact The Business
  • Claim ownership or report listing
  • Want your business to be the top-listed Pet Store/pet Service?

Share